The Excellence Program helps you reach patients faster with up to 50% lower R&D costs.
We will execute the (pre-) clinical translation of your compound at cost price till Phase III.
Together we will generate fast in-human data that allows you to get your drug on the market faster.
As a participant you are introduced to our large European and U.S. network of partners and investors.
Design FDA and EMA compliant clinical studies together with our regulatory experts.
Accelerate your drug development by using innovative molecular imaging techniques in your clinical trials.
Receive business development support from setting business goals to finding potential exit partners.
Contact us or book your intake now.